Karen Devine
Impact in
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Genetics top 0.2%
- Glioma Diagnosis and Treatment
Papers in
-
- Cancer Genomics and Diagnostics 23
- Oncology 11
- Cancer-related Molecular Pathways 5
- Pancreatic and Hepatic Oncology Research 4
- Co-authors
- Chad D. Morris (2 shared papers)Jeanette A. Waxmonsky (1 shared paper)H. Kim Jerome (1 shared paper)Vattipally B. Sreenu (1 shared paper)Celia Jackson (1 shared paper)Celia Aitken (1 shared paper)Ana Cristina da Silva Filipe (1 shared paper)Lisbeth Harder (1 shared paper)
- Journals
- Cell (11 papers)Cell Reports (11 papers)Cancer Cell (4 papers)Cell Systems (3 papers)Neuro-Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Karen Devine
42 papers receiving 24.4k citations
Karen Devine's Hit Papers
Peers
Comparison fields: 5 of 154
- Cancer Research 8.0k
- Genetics 3.6k
- Oncology 5.1k
- Molecular Biology 12.7k
- Pulmonary and Respiratory Medicine 4.1k
Countries citing papers authored by Karen Devine
This map shows the geographic impact of Karen Devine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Devine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Devine more than expected).
Fields of papers citing papers by Karen Devine
This network shows the impact of papers produced by Karen Devine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Devine. The network helps show where Karen Devine may publish in the future.
Co-authors
The 25 scholars most cited alongside Karen Devine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Somatic Genomic Landscape of Glioblastoma Hit paper breakdown → | 2013 | 3977 |
| 2 | An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics Hit paper breakdown → | 2018 | 2602 |
| 3 | Oncogenic Signaling Pathways in The Cancer Genome Atlas Hit paper breakdown → | 2018 | 2334 |
| 4 | Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer Hit paper breakdown → | 2018 | 1720 |
| 5 | Comprehensive Characterization of Cancer Driver Genes and Mutations Hit paper breakdown → | 2018 | 1714 |
| 6 | Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma Hit paper breakdown → | 2016 | 1643 |
| 7 | Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation Hit paper breakdown → | 2018 | 1617 |
| 8 | Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas Hit paper breakdown → | 2018 | 810 |
| 9 | Genomic and Functional Approaches to Understanding Cancer Aneuploidy Hit paper breakdown → | 2018 | 749 |
| 10 | Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients Hit paper breakdown → | 2018 | 685 |
| 11 | Pathogenic Germline Variants in 10,389 Adult Cancers Hit paper breakdown → | 2018 | 606 |
| 12 | Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Hit paper breakdown → | 2018 | 583 |
| 13 | The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma Hit paper breakdown → | 2018 | 569 |
| 14 | A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers Hit paper breakdown → | 2018 | 456 |
| 15 | Driver Fusions and Their Implications in the Development and Treatment of Human Cancers Hit paper breakdown → | 2018 | 451 |
| 16 | The Immune Landscape of Cancer Hit paper breakdown → | 2019 | 449 |
| 17 | 2018 | 392 | |
| 18 | Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer Hit paper breakdown → | 2018 | 372 |
| 19 | Comprehensive Characterization of Cancer Driver Genes and Mutations Hit paper breakdown → | 2018 | 372 |
| 20 | 2018 | 339 |
About Karen Devine
Karen Devine is a scholar working on Cancer Research, Oncology, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 45 papers that have together received 24.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (23 papers), Glioma Diagnosis and Treatment (6 papers), RNA modifications and cancer (5 papers), Cancer-related Molecular Pathways (5 papers), Ferroptosis and cancer prognosis (4 papers), Epigenetics and DNA Methylation (4 papers), Genetic factors in colorectal cancer (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Cancer Research (8.0k citations), Genetics (3.6k citations), Oncology (5.1k citations), Molecular Biology (12.7k citations) and Pulmonary and Respiratory Medicine (4.1k citations). Karen Devine has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Chad D. Morris, Jeanette A. Waxmonsky, H. Kim Jerome, Vattipally B. Sreenu, Celia Jackson, Celia Aitken, Ana Cristina da Silva Filipe, Lisbeth Harder, Shirin Ashraf and Emma C. Thomson. Their work appears in journals such as Cell, Cell Reports, Cancer Cell, Cell Systems and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.